0
checked

Defibrillators Market Worth 10.88 Billion USD by 2022 - Worldnews.com

submitted 1 week ago, Thursday, Jul 12, 2018, 13:29:35 by rosywills9 in Business
According to a new market research report " Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022 " , published by MarketsandMarkets™, the global market is projected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1%. Factors such as technological advancements
rated 0 times (+0)  (-0) - comments: 0 - hits: 17 - u.wn.com

Comments

There are no comments for this article.
Only authorized users can leave comments. Please sign in first, or register a free account.
 
Share
Sponsor
Published By
rosywills9

rosywills9

Member since Jul 4, 2018
Location: n/a
Following
User not following anyone yet.
You might also like
The global eHealth market is projected to reach USD 132.35 Billion by 2023 from USD 47.60 Billion in 2018, at a CAGR of 22.7%. The market is fragmented and highly-competitive in...
The global healthcare middleware market is expected to reach USD 3.07 Billion by 2023 from USD 1.90 Billion in 2018, at a CAGR of 10.0%.
According to a new market research report " Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D,...
The wearable medical devices market is expected to reach USD 14.41 Billion by 2022 from USD 6.22 Billion in 2017, at a CAGR of 18.3%.
The global market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, at a CAGR of 6.4%.
The report analyzes the contrast injector industry and studies the major market drivers, restraints/challenges, and opportunities. This market is expected to reach USD 636.1...
This report studies the preclinical imaging market over the forecast period of 2016 to 2021. The market is expected to reach USD 910.4 Million by 2021; growing at a CAGR of 6.2%...
The RSV diagnostics market is expected to reach USD 929.2 Million by 2022 from USD 574.3 Million in 2017, at a CAGR of 10.1%.